Buy Cediranib

Product Name: Cediranib
CAS: 288383-20-0
Molecular formula: C25H27FN4O3
Molecular Weight: 450.51
Product Description: A cytostatic orally, developed by US company Zeneca, trade name recentin, this product is an inhibitor of highly VEGFR tyrosine kinase may be any VEGFR tyrosine kinase known inhibition (including VEGFR - 2 VEGFR VEGFR - 1-3 and PDGFR), Western Nebuchadnezzar angiogenesis can inhibit VEGF-induced survival and angiogenesis and growth of human tumor xenograft cells. For non-small cell lung cancer (NSCLC) in patients with stage I study found that Nebuchadnezzar sildenafil use of the anti-tumor effect is remarkable in combination with the PC scheme. Ⅱ / Ⅲ BR24 study for west Nebuchadnezzar 30 mg was studied as a first-line treatment in patients with NSCLC regime, and prove to have its anti-tumor effect, but with a higher incidence of adverse events, including diarrhea, dehydration, the Brotherhood's syndrome, hypertension, and neutropenia.